BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/12/2016 1:04:00 PM | Browse: 1172 | Download: 2293
 |
Received |
|
2015-12-11 08:44 |
 |
Peer-Review Started |
|
2015-12-11 10:34 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2016-01-13 13:28 |
 |
Revised |
|
2016-01-18 20:43 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2016-01-28 14:13 |
 |
Second Decision by Editor-in-Chief |
|
2016-01-28 15:39 |
 |
Final Decision by Editorial Office Director |
|
2016-02-22 11:02 |
 |
Articles in Press |
|
2016-02-22 11:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-03-16 11:27 |
 |
Publish the Manuscript Online |
|
2016-04-03 18:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alexandra Alexopoulou, Larisa Vasilieva, Danai Agiasotelli, Kyriaki Siranidi, Sophia Pouriki, Athanasia Tsiriga, Marina Toutouza and Spyridon P Dourakis |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Alexandra Alexopoulou, MD, Assistant Professor of Medicine, 2nd Department of Internal Μedicine, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, 114 Vas Sophias St, 11527 Athens, Greece. alexopou@ath.forthnet.gr |
| Key Words |
Spontaneous bacterial peritonitis; Spontaneous bacteremia; Multidrug-resistant bacteria; Extensively drug-resistant bacteria; Susceptibility to antibiotics |
| Core Tip |
This is a prospective, observational, single Center study seeking to evaluate the epidemiology and outcomes of 130 patients with decompensated cirrhosis and culture-positive spontaneous bacterial peritonitis or spontaneous bacteremia. Both multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria were isolated in about one third of the cases. Patients with XDR demonstrated high mortality compared to the rest of the patients. All MDR/XDR associated infections were health-care associated and/or nosocomial. Independent factors adversely affected survival included XDR infection, renal dysfunction and coagulation disorder.
|
| Publish Date |
2016-04-03 18:51 |
| Citation |
Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, Toutouza M, Dourakis SP. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol 2016; 22(15): 4049-4056 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i15/4049.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i15.4049 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.